Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

Publikation

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

Wissenschaftlicher Artikel/Review - 13.09.2003

Jaggy Christian, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Flepp Markus, Battegay Manuel, Telenti Amalio, Furrer Hans-Jakob, Rickenbach Martin, Egger Matthias, Schwarz Claude, Ledergerber Bruno, von Overbeck Jan, Swiss HIV Cohort Study

Zitation

Jaggy C, Hirschel B, Bernasconi E, Vernazza P, Flepp M, Battegay M, Telenti A, Furrer H, Rickenbach M, Egger M, Schwarz C, Ledergerber B, von Overbeck J, Swiss HIV Cohort Study. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362:877-8.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Lancet 2003; 362

Veröffentlichungsdatum

13.09.2003

eISSN (Online)

1474-547X

Seiten

877-8

Kurzbeschreibung/Zielsetzung

Because of high death rates in the past, patients with HIV-1 cannot obtain life insurance. We measured mortality rates in the Swiss HIV Cohort Study (SHCS) from 1997 to 2001 and compared them with those of the Swiss reference population. In patients who were successfully treated with highly active anti-retroviral therapy (HAART), and who were not also infected with the hepatitis C virus, excess death rates were below five per thousand per year. Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies.